Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Chemotherapy-Induced Neutropenia Treatment Market Size, Status and Forecast 2022

  • QYR1055710
  • 96 Pages
  • March 2017
  • Medical Devices
Download Sample    Get Discount   
 

This report studies the global Chemotherapy-Induced Neutropenia Treatment market, analyzes and researches the Chemotherapy-Induced Neutropenia Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

Amgen

Sanofi

Novartis AG

Baxter International

Teva Pharmaceuticals Industries

Apotex

Dr. Reddy’s Laboratory

Biogenomics Limited

Ligand Pharmaceuticals

Market segment by Regions/Countries, this report covers

United States

EU

Japan

China

India

Southeast Asia

Market segment by Type, Chemotherapy-Induced Neutropenia Treatment can be split into

Antibiotic Therapy

Colony-Stimulating Factor Therapy

Granulocyte Transfusion

Splenectomy Procedure

Others

Market segment by Application, Chemotherapy-Induced Neutropenia Treatment can be split into

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Table of Contents

Global Chemotherapy-Induced Neutropenia Treatment Market Size, Status and Forecast 2022

1 Industry Overview of Chemotherapy-Induced Neutropenia Treatment

1.1 Chemotherapy-Induced Neutropenia Treatment Market Overview

1.1.1 Chemotherapy-Induced Neutropenia Treatment Product Scope

1.1.2 Market Status and Outlook

1.2 Global Chemotherapy-Induced Neutropenia Treatment Market Size and Analysis by Regions

1.2.1 United States

1.2.2 EU

1.2.3 Japan

1.2.4 China

1.2.5 India

1.2.6 Southeast Asia

1.3 Chemotherapy-Induced Neutropenia Treatment Market by Type

1.3.1 Antibiotic Therapy

1.3.2 Colony-Stimulating Factor Therapy

1.3.3 Granulocyte Transfusion

1.3.4 Splenectomy Procedure

1.3.5 Others

1.4 Chemotherapy-Induced Neutropenia Treatment Market by End Users/Application

1.4.1 Hospital Pharmacy

1.4.2 Retail Pharmacy

1.4.3 Online Pharmacy

2 Global Chemotherapy-Induced Neutropenia Treatment Competition Analysis by Players

2.1 Chemotherapy-Induced Neutropenia Treatment Market Size (Value) by Players (2016 and 2017)

2.2 Competitive Status and Trend

2.2.1 Market Concentration Rate

2.2.2 Product/Service Differences

2.2.3 New Entrants

2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles

3.1 Amgen

3.1.1 Company Profile

3.1.2 Main Business/Business Overview

3.1.3 Products, Services and Solutions

3.1.4 Chemotherapy-Induced Neutropenia Treatment Revenue (Value) (2012-2017)

3.1.5 Recent Developments

3.2 Sanofi

3.2.1 Company Profile

3.2.2 Main Business/Business Overview

3.2.3 Products, Services and Solutions

3.2.4 Chemotherapy-Induced Neutropenia Treatment Revenue (Value) (2012-2017)

3.2.5 Recent Developments

3.3 Novartis AG

3.3.1 Company Profile

3.3.2 Main Business/Business Overview

3.3.3 Products, Services and Solutions

3.3.4 Chemotherapy-Induced Neutropenia Treatment Revenue (Value) (2012-2017)

3.3.5 Recent Developments

3.4 Baxter International

3.4.1 Company Profile

3.4.2 Main Business/Business Overview

3.4.3 Products, Services and Solutions

3.4.4 Chemotherapy-Induced Neutropenia Treatment Revenue (Value) (2012-2017)

3.4.5 Recent Developments

3.5 Teva Pharmaceuticals Industries

3.5.1 Company Profile

3.5.2 Main Business/Business Overview

3.5.3 Products, Services and Solutions

3.5.4 Chemotherapy-Induced Neutropenia Treatment Revenue (Value) (2012-2017)

3.5.5 Recent Developments

3.6 Apotex

3.6.1 Company Profile

3.6.2 Main Business/Business Overview

3.6.3 Products, Services and Solutions

3.6.4 Chemotherapy-Induced Neutropenia Treatment Revenue (Value) (2012-2017)

3.6.5 Recent Developments

3.7 Dr. Reddy’s Laboratory

3.7.1 Company Profile

3.7.2 Main Business/Business Overview

3.7.3 Products, Services and Solutions

3.7.4 Chemotherapy-Induced Neutropenia Treatment Revenue (Value) (2012-2017)

3.7.5 Recent Developments

3.8 Biogenomics Limited

3.8.1 Company Profile

3.8.2 Main Business/Business Overview

3.8.3 Products, Services and Solutions

3.8.4 Chemotherapy-Induced Neutropenia Treatment Revenue (Value) (2012-2017)

3.8.5 Recent Developments

3.9 Ligand Pharmaceuticals

3.9.1 Company Profile

3.9.2 Main Business/Business Overview

3.9.3 Products, Services and Solutions

3.9.4 Chemotherapy-Induced Neutropenia Treatment Revenue (Value) (2012-2017)

3.9.5 Recent Developments

4 Global Chemotherapy-Induced Neutropenia Treatment Market Size by Type and Application (2012-2017)

4.1 Global Chemotherapy-Induced Neutropenia Treatment Market Size by Type (2012-2017)

4.2 Global Chemotherapy-Induced Neutropenia Treatment Market Size by Application (2012-2017)

4.3 Potential Application of Chemotherapy-Induced Neutropenia Treatment in Future

4.4 Top Consumer/End Users of Chemotherapy-Induced Neutropenia Treatment

5 United States Chemotherapy-Induced Neutropenia Treatment Development Status and Outlook

5.1 United States Chemotherapy-Induced Neutropenia Treatment Market Size (2012-2017)

5.2 United States Chemotherapy-Induced Neutropenia Treatment Market Size and Market Share by Players (2016 and 2017)

6 EU Chemotherapy-Induced Neutropenia Treatment Development Status and Outlook

6.1 EU Chemotherapy-Induced Neutropenia Treatment Market Size (2012-2017)

6.2 EU Chemotherapy-Induced Neutropenia Treatment Market Size and Market Share by Players (2016 and 2017)

7 Japan Chemotherapy-Induced Neutropenia Treatment Development Status and Outlook

7.1 Japan Chemotherapy-Induced Neutropenia Treatment Market Size (2012-2017)

7.2 Japan Chemotherapy-Induced Neutropenia Treatment Market Size and Market Share by Players (2016 and 2017)

8 China Chemotherapy-Induced Neutropenia Treatment Development Status and Outlook

8.1 China Chemotherapy-Induced Neutropenia Treatment Market Size (2012-2017)

8.2 China Chemotherapy-Induced Neutropenia Treatment Market Size and Market Share by Players (2016 and 2017)

9 India Chemotherapy-Induced Neutropenia Treatment Development Status and Outlook

9.1 India Chemotherapy-Induced Neutropenia Treatment Market Size (2012-2017)

9.2 India Chemotherapy-Induced Neutropenia Treatment Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Chemotherapy-Induced Neutropenia Treatment Development Status and Outlook

10.1 Southeast Asia Chemotherapy-Induced Neutropenia Treatment Market Size (2012-2017)

10.2 Southeast Asia Chemotherapy-Induced Neutropenia Treatment Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)

11.1 Global Chemotherapy-Induced Neutropenia Treatment Market Size (Value) by Regions (2017-2022)

11.1.1 United States Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2017-2022)

11.1.2 EU Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2017-2022)

11.1.3 Japan Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2017-2022)

11.1.4 China Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2017-2022)

11.1.5 India Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2017-2022)

11.1.6 Southeast Asia Chemotherapy-Induced Neutropenia Treatment Revenue and Growth Rate (2017-2022)

11.2 Global Chemotherapy-Induced Neutropenia Treatment Market Size (Value) by Type (2017-2022)

11.3 Global Chemotherapy-Induced Neutropenia Treatment Market Size by Application (2017-2022)

12 Chemotherapy-Induced Neutropenia Treatment Market Dynamics

12.1 Chemotherapy-Induced Neutropenia Treatment Market Opportunities

12.2 Chemotherapy-Induced Neutropenia Treatment Challenge and Risk

12.2.1 Competition from Opponents

12.2.2 Downside Risks of Economy

12.3 Chemotherapy-Induced Neutropenia Treatment Market Constraints and Threat

12.3.1 Threat from Substitute

12.3.2 Government Policy

12.3.3 Technology Risks

12.4 Chemotherapy-Induced Neutropenia Treatment Market Driving Force

12.4.1 Growing Demand from Emerging Markets

12.4.2 Potential Application

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs Trend/Customer Preference

13.3 External Environmental Change

13.3.1 Economic Fluctuations

13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Chemotherapy-Induced Neutropenia Treatment Product Scope

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) (2012-2017)

Table Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Share by Regions in 2016

Figure United States Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure EU Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Japan Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure China Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure India Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Southeast Asia Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Share by Type in 2016

Figure Antibiotic Therapy Market Size (Million USD) and Growth Rate (2012-2017)

Figure Colony-Stimulating Factor Therapy Market Size (Million USD) and Growth Rate (2012-2017)

Figure Granulocyte Transfusion Market Size (Million USD) and Growth Rate (2012-2017)

Figure Splenectomy Procedure Market Size (Million USD) and Growth Rate (2012-2017)

Figure Others Market Size (Million USD) and Growth Rate (2012-2017)

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Share by Application in 2016

Figure Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) and Growth Rate in Hospital Pharmacy (2012-2017)

Figure Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) and Growth Rate in Retail Pharmacy (2012-2017)

Figure Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) and Growth Rate in Online Pharmacy (2012-2017)

Table Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Players (2016 and 2017)

Figure Chemotherapy-Induced Neutropenia Treatment Market Size Share by Players in 2016

Figure Chemotherapy-Induced Neutropenia Treatment Market Size Share by Players in 2017

Table Amgen Basic Information List

Table Chemotherapy-Induced Neutropenia Treatment Business Revenue (Million USD) of Amgen (2012-2017)

Figure Amgen Chemotherapy-Induced Neutropenia Treatment Business Revenue Market Share in 2016

Table Sanofi Basic Information List

Table Chemotherapy-Induced Neutropenia Treatment Business Revenue (Million USD) of Sanofi (2012-2017)

Figure Sanofi Chemotherapy-Induced Neutropenia Treatment Business Revenue Market Share in 2016

Table Novartis AG Basic Information List

Table Chemotherapy-Induced Neutropenia Treatment Business Revenue (Million USD) of Novartis AG (2012-2017)

Figure Novartis AG Chemotherapy-Induced Neutropenia Treatment Business Revenue Market Share in 2016

Table Baxter International Basic Information List

Table Chemotherapy-Induced Neutropenia Treatment Business Revenue (Million USD) of Baxter International (2012-2017)

Figure Baxter International Chemotherapy-Induced Neutropenia Treatment Business Revenue Market Share in 2016

Table Teva Pharmaceuticals Industries Basic Information List

Table Chemotherapy-Induced Neutropenia Treatment Business Revenue (Million USD) of Teva Pharmaceuticals Industries (2012-2017)

Figure Teva Pharmaceuticals Industries Chemotherapy-Induced Neutropenia Treatment Business Revenue Market Share in 2016

Table Apotex Basic Information List

Table Chemotherapy-Induced Neutropenia Treatment Business Revenue (Million USD) of Apotex (2012-2017)

Figure Apotex Chemotherapy-Induced Neutropenia Treatment Business Revenue Market Share in 2016

Table Dr. Reddy’s Laboratory Basic Information List

Table Chemotherapy-Induced Neutropenia Treatment Business Revenue (Million USD) of Dr. Reddy’s Laboratory (2012-2017)

Figure Dr. Reddy’s Laboratory Chemotherapy-Induced Neutropenia Treatment Business Revenue Market Share in 2016

Table Biogenomics Limited Basic Information List

Table Chemotherapy-Induced Neutropenia Treatment Business Revenue (Million USD) of Biogenomics Limited (2012-2017)

Figure Biogenomics Limited Chemotherapy-Induced Neutropenia Treatment Business Revenue Market Share in 2016

Table Ligand Pharmaceuticals Basic Information List

Table Chemotherapy-Induced Neutropenia Treatment Business Revenue (Million USD) of Ligand Pharmaceuticals (2012-2017)

Figure Ligand Pharmaceuticals Chemotherapy-Induced Neutropenia Treatment Business Revenue Market Share in 2016

Table Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Type (2012-2017)

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size Share by Type in 2012

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size Share by Type in 2013

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size Share by Type in 2014

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size Share by Type in 2015

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size Share by Type in 2016

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size Share by Type in 2017

Table Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Application (2012-2017)

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Application in 2012

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Application in 2013

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Application in 2014

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Application in 2015

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Application in 2016

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Application in 2017

Table Top Consumer/End Users of Chemotherapy-Induced Neutropenia Treatment

Figure United States Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table United States Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Players (2012-2017)

Figure United States Chemotherapy-Induced Neutropenia Treatment Market Size Share by Players in 2016

Figure United States Chemotherapy-Induced Neutropenia Treatment Market Size Share by Players in 2017

Figure EU Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table EU Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Players (2012-2017)

Figure EU Chemotherapy-Induced Neutropenia Treatment Market Size Share by Players in 2016

Figure EU Chemotherapy-Induced Neutropenia Treatment Market Size Share by Players in 2017

Figure Japan Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table Japan Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Players (2012-2017)

Figure Japan Chemotherapy-Induced Neutropenia Treatment Market Size Share by Players in 2016

Figure Japan Chemotherapy-Induced Neutropenia Treatment Market Size Share by Players in 2017

Figure China Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table China Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Players (2012-2017)

Figure China Chemotherapy-Induced Neutropenia Treatment Market Size Share by Players in 2016

Figure China Chemotherapy-Induced Neutropenia Treatment Market Size Share by Players in 2017

Figure India Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table India Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Players (2012-2017)

Figure India Chemotherapy-Induced Neutropenia Treatment Market Size Share by Players in 2016

Figure India Chemotherapy-Induced Neutropenia Treatment Market Size Share by Players in 2017

Figure Southeast Asia Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table Southeast Asia Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Players (2012-2017)

Figure Southeast Asia Chemotherapy-Induced Neutropenia Treatment Market Size Share by Players in 2016

Figure Southeast Asia Chemotherapy-Induced Neutropenia Treatment Market Size Share by Players in 2017

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Regions (2017-2022)

Table Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Regions (2017-2022)

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size Share by Regions in 2017

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size Share by Regions in 2022

Figure United States Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) and Growth Rate (2017-2022)

Figure EU Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) and Growth Rate (2017-2022)

Figure Japan Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) and Growth Rate (2017-2022)

Figure China Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) and Growth Rate (2017-2022)

Figure India Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) and Growth Rate (2017-2022)

Figure Southeast Asia Chemotherapy-Induced Neutropenia Treatment Revenue (Million USD) and Growth Rate (2017-2022)

Table Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Type (2017-2022)

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size Share by Type in 2017

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size Share by Type in 2022

Table Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Application (2017-2022)

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Application in 2017

Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size (Million USD) by Application in 2022

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370